 Agios Pharmaceuticals, Inc. NASDAQ:AGIO Q2 2020 Results Earnings Conference Call July 30, 2020, 08:00 AM ET Company Participants Holly Manning - Director of Investor Relations Jacqualyn Fouse - Chief Executive Officer Chris Bowden - Chief Medical Officer Darrin Miles - SVP, U.S. 